Optimization of methods for intrasplenic administration of human amniotic epithelial cells in order to perform safe and effective cell-based therapy for liver diseases
Piotr Czekaj(Medical University of Silesia), Agnieszka Prusek(Medical University of Silesia), Patrycja Wieczorek(Medical University of Silesia), Mateusz Hermyt(Medical University of Silesia), Aniela Grajoszek(Medical University of Silesia), Edyta Bogunia(Medical University of Silesia), Emanuel Kolanko(Jagiellonian University), Mateusz Król(Medical University of Silesia)
Cited by 0
Related Papers
The evolution of<i>in vitro</i>models of lung fibrosis: promising prospects for drug discovery
|European Respiratory Review|2024|43
Increased immunomodulatory capacity of human amniotic cells after activation by pro-inflammatory chemokines
|European Journal of Pharmacology|2019|25
Dynamics of Acute Liver Injury in Experimental Models of Hepatotoxicity in the Context of Their Implementation in Preclinical Studies on Stem Cell Therapy
|Frontiers in Bioscience-Landmark|2022|9
The relationship between amniotic epithelial cells and their microenvironment
|Journal of Applied Biomedicine|2015|8
Thromboprophylaxis in hospitalized COVID-19 patients: the efficacy and safety of the approved hospital protocol
|Polskie Archiwum Medycyny Wewnętrznej|2021|7